According to a market report by Lucintel, the future of the global enteric disease testing market looks promising with opportunities in the water and food markets. The global enteric disease testing market is expected to reach an estimated $5.1 billion by 2030 with a CAGR of 3.5% from 2024 to 2030. The major drivers for this market are rising number of innovations and technological advancements in enteric disease testing devices, increasing focus on sample utilization, and growing advancement for quicker, proficient, and cheaper computing hardware tied with better network connectivity.
A more than 150-page report to understand trends, opportunity and forecast in enteric disease testing market to 2030 by technology (traditional, rapid, convenience-based, polymerase chain reaction, immunoassay, and chromatography & spectrometry), end use (food and water), and region (North America, Europe, Asia Pacific, and the Rest of the World).
Lucintel forecasts that, within the technology category, traditional testing will remain the largest segment over the forecast period due to growing demand for processed and convenience food, as well as, increasing incidences of enteric diseases.
Download sample by clicking on enteric disease testing market
In terms of regions, North America will remain the largest segment over the forecast period due to the rising incidences of enteric diseases and increasing regulatory efforts for spreading awareness regarding the availability of enteric diseases in this region.
Merck, Thermo Fisher Scientific, SGS, Eurofins Scientific, Bureau Veritas, Intertek, Romer Labs, Perkinelmer, Becton Dickinson are the major suppliers in the enteric disease testing market.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at [email protected] To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: [email protected]
Tel. +1-972-636-5056
Explore Our Latest Publications
Immortalized Cell Line Market
Liposuction Surgery Device Market
Retinal Imaging Device Market
X-Linked Hypophosphatemia Market
Advanced Tire Market
Automotive Catalytic Converter Market
Automotive Interior Market